CATHLEEN VANESSA EXCONDE-MERCADO: Open Payments
NPI 1518674605 · BEAUMONT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 55 payments from 12 companies in 2025. Trend: 2023 $121 · 2024 $850 · 2025 $1,108
Food & beverage: $1,013Education: $95
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $206 |
| E.R. Squibb & Sons, L.L.C. | 11 | $196 |
| Janssen Biotech, Inc. | 6 | $191 |
| Incyte Corporation | 10 | $162 |
| ABBVIE INC. | 17 | $160 |
| GENZYME CORPORATION | 1 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| LEO Pharma Inc. | 1 | $29 |
| Amgen Inc. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
Products named: Bimzelx, Sotyktu, TREMFYA, OPZELURA, RINVOQ, SKYRIZI, DUPIXENT, ADBRY.
Industry payments across CA — which companies pay providers there.
